IBIO vs TENX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

IBIO

45.7
AI Score
VS
IBIO Wins

TENX

38.3
AI Score

Investment Advisor Scores

IBIO

46score
Recommendation
BUY

TENX

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric IBIO TENX Winner
Forward P/E 0 0.299 Tie
PEG Ratio 0 1.4428 Tie
Revenue Growth -100.0% 0.0% TENX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.7/100 38.3/100 IBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation BUY AVOID NEW MONEY IBIO

Relative Price Performance (Last 90 Days)

IBIO 1M: -2.4% · 3M: -46.7% TENX 1M: +4.9% · 3M: -10.6%

Current Technical Phase

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.3%), weak momentum, RSI 41

RSI (14): 41.3 · Price: $0.76

TENX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -22.4%), weak momentum, RSI 37

RSI (14): 36.6 · Price: $1.61

Fundamentals Snapshot

Metric IBIO TENX
Market Cap — —
Forward P/E -2.5 -1.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin 1.0% —
Operating Margin -301.4% 0.0%
EPS -0.27 -1.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.